DANIELLE LEEPER: Open Payments
NPI 1669924817 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,737 in 80 payments from 11 companies in 2025. Trend: 2023 $1,110 · 2024 $1,283 · 2025 $1,737
Food & beverage: $1,737
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 25 | $512 |
| Gilead Sciences, Inc. | 12 | $354 |
| Merck Sharp & Dohme LLC | 8 | $166 |
| Paratek Pharmaceuticals, Inc. | 9 | $154 |
| ABBVIE INC. | 9 | $138 |
| Melinta Therapeutics, LLC | 5 | $124 |
| Insmed, Inc. | 6 | $120 |
| Aimmune Therapeutics, Inc. | 3 | $100 |
| Astellas Pharma US Inc | 1 | $29 |
| Shionogi Inc | 1 | $24 |
Products named: DOVATO, CABENUVA, NUZYRA, PIFELTRO, Rezzayo, Arikayce, VOWST, DALVANCE.
Industry payments across AR — which companies pay providers there.
